48 C.F.R. § 27.204-1

Use of patented technology under the United States-Mexico-Canada Agreement.

Last amended: 2022Year: 2026Length: 41 wordsOfficial source

Cite as 48 C.F.R. § 27.204-1 (2026)

When questions arise with regard to use of patented technology under the United States-Mexico-Canada Agreement, the contracting officer should consult with legal counsel. Note that Article 20.6(a) of the Agreement discusses public health and pharmaceuticals. [87 FR 73892, Dec. 1, 2022]
48 C.F.R. § 27.204-1: Use of patented technology under the United States-Mexico-Canada Agreement. | Justis AI